Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloma-Developing Regimens Using Genomics (MyDRUG) (Genomics Guided Multi-arm Trial of Targeted Agents Alone or in Combination With a Backbone Regimen)

NCT03732703 is registered in ClinicalTrials.gov with Multiple Myeloma Research Consortium as lead sponsor.

NCT NCT03732703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03732703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloma-Developing Regimens Using Genomics (MyDRUG) (Genomics Guided Multi-arm Trial of Targeted Agents Alone or in Combination With a Backbone Regimen)
Lead sponsor
Multiple Myeloma Research Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
April 1, 2019
Completion date
December 31, 2024
Enrollment
103 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed refractory multiple myeloma